Mark Douglas
Vice President - Head of CMC
Boston, Massachusetts, United States
Professional Overview
Mark Douglas is an experienced pharmaceutical executive with a proven track record of leading Chemistry, Manufacturing, and Controls (CMC) operations for innovative biotechnology companies. As the Vice President - Head of CMC at Jnana Therapeutics, he is responsible for overseeing all aspects of the company's CMC strategy, ensuring the seamless development and manufacturing of their novel therapeutic candidates.
Experience Summary
Current Role
As the Vice President - Head of CMC at Jnana Therapeutics, Mark is responsible for the comprehensive management of the company's CMC operations. He leads a team of subject matter experts to develop and implement robust manufacturing processes, ensure regulatory compliance, and drive continuous improvements to enhance the efficiency and reliability of Jnana's supply chain. Under his leadership, the company has successfully navigated critical milestones, including the scale-up of lead candidate production and the initiation of multiple clinical trials.
Career Progression
Prior to his current role, Mark held progressive leadership positions at other prominent biotechnology companies. As the Vice President - CMC and Executive Director - CMC at MapLight Therapeutics, he played a pivotal role in advancing the company's pipeline, overseeing the development and manufacturing of their innovative therapies. Before that, he served in various roles at Flexion Therapeutics, where he contributed to the successful commercialization of a novel osteoarthritis treatment. Mark's early career experience at Infinity Pharmaceuticals further solidified his expertise in pharmaceutical development and translational science.
Academic Background
Mark holds a Ph.D. in Pharmaceutical Sciences from the University of Massachusetts, where his research focused on improving the solubility and bioavailability of small molecule drugs. He also obtained a Bachelor of Science degree in Chemistry from the University of Rhode Island, graduating with Magna Cum Laude honors.
Areas of Expertise
- Chemistry, Manufacturing, and Controls (CMC) strategy and operations
- Pharmaceutical development and scale-up
- Quality assurance and regulatory compliance
- Cross-functional team leadership and collaboration
- Innovative problem-solving and continuous improvement
Professional Impact
Throughout his career, Mark has made significant contributions to the advancement of novel therapies. At Jnana Therapeutics, he has played a pivotal role in the successful development and manufacturing of the company's lead candidate, which has demonstrated promising results in early-stage clinical trials. His expertise in CMC has been instrumental in navigating complex regulatory requirements and ensuring the reliable supply of Jnana's therapeutic pipeline.
Conclusion
With his extensive experience in the pharmaceutical industry and proven leadership in CMC operations, Mark Douglas is a valuable asset to Jnana Therapeutics. His strategic vision, technical expertise, and collaborative approach have been instrumental in driving the company's growth and positioning its novel therapies for success in the highly competitive biotechnology market.
